[Skip to Navigation]
Viewpoint
Health Care Policy and Law
February 2017

Promotion of Drugs for Off-label Uses: The US Food and Drug Administration at a Crossroads

Author Affiliations
  • 1Yale Law School, New Haven, Connecticut
JAMA Intern Med. 2017;177(2):157-158. doi:10.1001/jamainternmed.2016.7151
Add or change institution
×